title: A novel permeation enhancer: N-succinyl chitosan on the intranasal absorption of isosorbide dinitrate in rats.
abstract: The purpose of this paper is to study the potential of N-succinyl chitosan as a novel permeation enhancer for the intranasal absorption of isosorbide dinitrate (ISDN). A series of N-succinyl chitosan (NSCS) with different degree of succinylation (DS) and molecular weight were synthesized. An in situ nasal perfusion technique in rats was utilized to investigate the effect of NSCS substitution degree, NSCS molecular weight and concentration on the intranasal absorption of ISDN. The absorption enhancing effect of NSCS was compared with that of chitosan. It was found that all the NSCS investigated improved the intranasal absorption of ISDN remarkably. Better promoting effect was observed for 0.1% NSCS 50 (63) compared with 0.5% chitosan 50. In nasal ciliotoxicity test, both NSCS and chitosan investigated showed good safety profiles. Thereafter, in vivo studies of the selected formulations were carried out in rats and the pharmacokinetic parameters were calculated and compared with that of intravenous injection. Both in situ and in vivo studies demonstrated that NSCS is more effective than chitosan in promoting intranasal absorption of ISDN. Taking both absorption enhancing and safety reason into account, we suggest NSCS is a promising intranasal absorption enhancer.
authors.affiliation: School of Pharmacy, Shenyang Pharmaceutical University, 103 Wenhua Road, 32#, Shenyang 110016, China.
authors.forename: Lidong
authors.initials: L
authors.lastname: Na
authors.forename: Juan
authors.initials: J
authors.lastname: Wang
authors.forename: Linlin
authors.initials: L
authors.lastname: Wang
authors.forename: Shirui
authors.initials: S
authors.lastname: Mao
mesh_terms: D000042:Absorption / Q000187:drug effects; D000281:Administration, Intranasal; D000818:Animals; D002023:Bufo bufo; D048271:Chitosan / Q000008:administration & dosage* / Q000737:chemistry; D005260:Female; D007548:Isosorbide Dinitrate / Q000008:administration & dosage / Q000493:pharmacokinetics*; D008297:Male; D008970:Molecular Weight; D009297:Nasal Mucosa / Q000378:metabolism*; D020030:Nitric Oxide Donors / Q000008:administration & dosage / Q000493:pharmacokinetics*; D051381:Rats; D017208:Rats, Wistar
chemical_list: C118639:N-succinyl-chitosan; D020030:Nitric Oxide Donors; D048271:Chitosan; D007548:Isosorbide Dinitrate